In-House vs Managed vs Franchise Pharmacy: Which to Choose?
In-house, managed and franchise hospital pharmacy models compared on cost, control, staffing and revenue, with a decision framework for your facility.

This compares all three on the things that matter most: control, upfront capital, staffing responsibility, ongoing risk, and revenue, before walking through each in detail.
How do the three models compare at a glance?
The table below summarises the core tradeoffs. Read the sections that follow for what each row actually means in practice, since a licence-holder or a revenue-share number means little without the operational context behind it.
| In-house | Managed | Franchise | |
|---|---|---|---|
| Who holds the drug licence | Hospital | Usually the operator | Usually the franchisee |
| Upfront capital | Highest — fit-out, full inventory, systems | Low to none | Moderate — franchise fee plus fit-out |
| Staffing responsibility | Hospital hires and manages pharmacist(s) | Operator hires and manages staff | Franchisee hires, often under brand training standards |
| Ongoing risk | Fully with the hospital | Shared, weighted toward the operator | Fully with the franchisee |
| Revenue | 100% of pharmacy revenue | Revenue share with operator | Revenue minus franchise fee and royalties |
| Brand | Hospital's own | Usually low-visibility or co-branded | Established retail pharmacy brand |
What does in-house actually require?
In-house means the hospital owns the drug licence, hires and manages the registered pharmacist directly, and carries the full inventory and working-capital burden itself. It also means full integration: the pharmacy ties directly into the hospital's own electronic records and clinical workflows, which is the strongest argument for it in facilities where inpatient safety depends on tight coordination between prescribing and dispensing.
The cost of that control is real. Setup alone commonly runs ₹5–15 lakh for a standalone unit. Every rupee of ongoing inventory, staffing and compliance risk sits with the hospital afterward, with no operator to share the burden if something goes wrong. Our full setup guide and cost breakdown cover exactly what building in-house involves.
What does managed actually require?
A managed pharmacy hands licensing, staffing and procurement to an external operator, who typically holds the licence in their own name under the most common version of this model. In exchange for that responsibility and the working capital it requires, the operator takes a share of pharmacy revenue rather than charging the hospital a flat fee.
This is the lowest-capital option of the three for the hospital, and it's why hospitals with limited administrative bandwidth for non-clinical operations lean toward it. The tradeoff is reduced autonomy. The hospital doesn't set pricing or stock decisions directly, and the quality of the arrangement depends entirely on which managed-pharmacy sub-model is actually being offered. Our managed pharmacy services guide breaks down the three sub-variants and what to check before signing.
What does franchise actually require?
A franchise pharmacy licenses an established retail pharmacy brand name, bringing immediate name recognition for attracting outpatient foot traffic, plus a standardised supply chain and training system from the parent company. It sits between the other two on capital. Less than building in-house from scratch, but more than a pure managed arrangement, since franchise agreements typically require an upfront franchise fee before any medicines are sold.
The ongoing cost is royalties, which apply regardless of whether the store is having a good month. That recurring fee squeezes margin in a way neither of the other two models does in quite the same form. Franchise also fits a hospital's outpatient-facing retail block better than it fits a pharmacy meant to serve inpatient clinical needs, since the brand relationship is built around retail customers rather than ward-level dispensing.
Which model fits which kind of hospital?
A large hospital with an existing purchasing and compliance team, and a genuine need for the pharmacy to be tightly wired into inpatient clinical workflows, is the clearest case for in-house. The administrative capacity already exists, so the extra burden the pharmacy adds is proportionally smaller.
A smaller nursing home or a hospital whose administration is already stretched across clinical priorities is usually better served by managed, precisely because it removes an entire category of non-clinical work rather than adding to an already full plate. A hospital whose pharmacy is primarily outpatient-facing, competing for walk-in retail footfall from the surrounding neighbourhood, is where franchise brand recognition earns its keep in a way it wouldn't for a pharmacy serving mostly admitted patients.
What questions decide it, regardless of size?
Three questions cut through the model choice faster than bed count alone. How much working capital can genuinely sit in medicine inventory without straining the hospital's cash flow elsewhere? How much administrative bandwidth exists to manage licensing renewals, staffing gaps and compliance across however many locations the hospital operates? And is the pharmacy primarily serving inpatients who need tight clinical integration, or outpatients who respond more to brand and convenience?
Answer those honestly before comparing revenue-share percentages or franchise fee schedules, because the right structural fit changes what those numbers actually mean for your facility.
A 200-bed hospital with an existing purchasing department can absorb an in-house pharmacy's demands without noticing much extra strain. A 20-bed nursing home run by two or three people has no such slack, and the same in-house model that suits the larger facility would consume disproportionate attention at the smaller one.
What happens if a hospital never actively chooses?
Hospitals that don't deliberately decide between these three models often default to no pharmacy decision at all, which in practice means patients fill every prescription outside the building. That default is the most expensive option of the four available, even though no invoice ever shows the cost directly. It shows up instead as pharmacy revenue that never reaches the hospital at all.
Our detailed breakdown of prescription leakage and hospital revenue loss covers exactly how large that gap tends to be and what closing it is worth.
Whichever way you land, on managed vs franchise pharmacy or in-house entirely, the worst outcome is no decision at all, left to drift by default while patients quietly take their prescriptions elsewhere.
Sources
- 1Central Drugs Standard Control Organisation — Drugs and Cosmetics Act, 1940 and Rules, 1945
- 2Pharmacy Council of India — registration requirements under the Pharmacy Act, 1948
- 3Improving Efficiency in Hospital Pharmacy Services — National Institutes of Health, National Library of Medicine
- 4Hospital Pharmacy Management — Management Sciences for Health
- 5Clinical Establishments Act, 2010 — Ministry of Health and Family Welfare
Find your best model
Get a free, hospital-specific comparison from the Medyzen team.
This article is for informational purposes and is not a substitute for professional legal or business advice. Verify current regulatory requirements with your state Drug Control department before choosing a pharmacy model.
FAQ
Frequently asked questions
In the hospital context, the three models are in-house (hospital-owned and operated), managed (operated by an external company under contract), and franchise (operated under a licensed retail pharmacy brand). Each shifts control, cost and risk differently between the hospital and the operator.
An in-house pharmacy is one owned, licensed and staffed directly by the hospital itself, physically located within the facility and integrated into its clinical and billing systems, as opposed to being run by an external company or under a franchise brand.
There's no universal answer — the right franchise depends on your outpatient footfall, your local market, and the specific supply chain and training support each brand offers. Compare royalty structure and initial franchise fee carefully, since those recurring costs vary more between brands than the headline pitch usually suggests.
Yes, though switching from managed or franchise back to in-house, or the reverse, involves winding down or transferring an existing drug licence and re-establishing staffing and inventory under the new structure. It's a real project, not a simple contract swap, so weigh the decision carefully rather than treating it as easily reversible.
Dr. Anurag SharmaMBBS, M.S. Orthopaedics
Consultant Orthopaedic Surgeon
Dr. Anurag Sharma is a Consultant Orthopaedic Surgeon specializing in Joint Replacement & Preservation and Sports Injury & Arthroscopy. He holds an M.S. in Orthopaedics from S.M.S. Medical College, Jaipur, a fellowship in Joint Replacement and Pelvi-acetabular Surgeries under Dr. Ramesh Sen, and an Executive Program in Public Health Policy, Leadership and Management from AIIMS Jodhpur.